Role of Toll-Like Receptor 4 (TLR4) in the Development of Inflammatory Process in Skin of Psoriasis Patients
The objective of the research was to study the mechanisms of developing local immune inflammation considering changes in immunohistochemical expression of Toll-like receptor 4 (TLR4) in skin of psoriasis patients after systemic immunosuppressive therapy.
Materials and methods. Immonohistochemical dynamic analysis of biopsy material taken from psoriaform skin areas in 62 psoriasis patients receiving systemic immunosuppressive therapy was made. Beyond that, to compare the results of the appropriate immunohistochemical examinations biopsy material from anterior abdominal wall taken after surgical intervention (e.g. hernia repair) in practically healthy persons of an appropriate age (5 patients) was studied. To determine the nature and area of local cellular immune and inflammatory reactions in skin of psoriasis patients, immunohistochemical techniques for determining TLR4 marker expression were used.
Results and discussion. While studying TLR4 expression, background diffuse cytoplasmic and nuclear staining of epidermis, vascular endothelium and single macrophage cells were identified in psoriaform skin areas. The number of positive-stained epidermis cells was about 80%. After a course of systemic suppressive therapy with Etanercept during 3 months, immunohistochemical reaction to identify TLR4 expression allowed us to establish that both the number of positive-stained cells and response intensity in epidermis considerably reduced. The number of cells expressing TLR4 in the epidermis was up to 60%. Even after treatment, a considerable number of TLR4-positive dendrite cells with a greatly increased size and extended with their processes up to the horny layer were identified in the epidermis.
Conclusions. The ligands activating toll-like receptors of macrophages and subsequent inflammatory reaction probably concentrate in epidermis dendrite cells as evidenced by immunohistochemical reactions. TLR4-positive macrophages after activation in dermal papilla migrate to the papilla base to be then included as a component of inflammatory perivascular infiltrates. After treatment, the number of cells (both dendrite and macrophage) with TLR expression significantly decreased. However, the background readiness to a burst of activity of toll-like receptors persists.
Medzhytov R. Dzhanevey Ch. Innate Immunity. Kazanskiy med zhurn. 2004; 85 (3): 161-67.
Tolstopyatova MA, Buslayeva GA, Kozlov IG. Role of innate immunity receptors in development of infectious pathology in new-born children. Pediatriya. 2009; 87: 115-120.
Khaitov RM, Ignatyeva GA, Sidorovich IG. Immunology. Norm and pathology. Moscow. Meditsina. 2010; 111-164.
Sandor F, Buc M. Toll-like Receptors. I. Structure, Function and Their Ligands. Folia biol (Praha). 2005; 51: 148-156.
James E, Mclnturff R, Modlin JK. The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J invest Derm. 2005; 1: 1-8.
Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001; 2: 675-680.
Curry JL, Qin JZ, Bonish B, et al. Innate immune-related receptors in normal and psoriatic skin. Arch Path Lab Med. 2003; 127: 178-186.
Takeda K, Akira S. Toll-receptors in innate immunity. Int Immunol. 2005; 17: 1-14.
Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol. 2007; 7 (3): 179-190.
Medzitov R. Toll-like receptors in innate immunity. New Engl J Med. 2000; 1: 343—344.
Janeway CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002; 20: 197–2016.
Kopp EB, Medzhitov R. The Toll-receptor family and control of innate immunity. Curr Opit Immunol. 1999; 11: 13-28.
Copyright (c) 2016 R. L. Stepanenko
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).